In SARS-CoV infection, the IL-8 induction signaling pathway is perhaps related to angiotensin-converting enzyme 2 (ACE2), as anti-ACE2 antibodies inhibit IL-8 induction/release [34]. Here, CXCL8 is linked to severe acute respiratory syndrome.